These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31707106)

  • 1. Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids.
    Kamble SH; Sharma A; King TI; Berthold EC; León F; Meyer PKL; Kanumuri SRR; McMahon LR; McCurdy CR; Avery BA
    Toxicol Lett; 2020 Feb; 319():148-154. PubMed ID: 31707106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of the main metabolites of Apatinib on CYP450 isozymes in human and rat liver microsomes.
    Pang NH; Xu RA; Chen LG; Chen Z; Hu GX; Zhang BW
    Toxicol In Vitro; 2024 Mar; 95():105739. PubMed ID: 38042355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolite profiling and identification of enzymes responsible for the metabolism of mitragynine, the major alkaloid of
    Kamble SH; Sharma A; King TI; León F; McCurdy CR; Avery BA
    Xenobiotica; 2019 Nov; 49(11):1279-1288. PubMed ID: 30547698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Herb-Drug Interaction of Synacinn™ and Individual Biomarker through Cytochrome 450 Inhibition Assay.
    Ab Rahman NS; Abd Majid FA; Abd Wahid ME; Zainudin AN; Zainol SN; Ismail HF; Wong TS; Tiwari NK; Giri S; Bhargava V
    Drug Metab Lett; 2018; 12(1):62-67. PubMed ID: 29542427
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Zhang C; Li Y; Yin C; Zheng J; Liu G
    Pharm Biol; 2021 Dec; 59(1):935-940. PubMed ID: 35294326
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Xu S; Zhang F; Chen D; Su K; Zhang L; Jiang R
    Pharm Biol; 2020 Dec; 58(1):308-313. PubMed ID: 32285742
    [No Abstract]   [Full Text] [Related]  

  • 7. Anemarsaponin BII inhibits the activity of CYP3A4, 2D6, and 2E1 with human liver microsomes.
    Wang M; Jiang W; Zhou J; Xue X; Yin C
    Pharm Biol; 2020 Dec; 58(1):1064-1069. PubMed ID: 33103940
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Li M; Liu X; Wang Y; Ju X
    Xenobiotica; 2020 Oct; 50(10):1202-1207. PubMed ID: 32338127
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Li Y; Qin J; Wu H; Xu Y; Zhang L; Su K; Cui Y; Wang H
    Pharm Biol; 2020 Dec; 58(1):695-700. PubMed ID: 32673137
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Zhang N; Liu J; Chen Z; Dou W
    Pharm Biol; 2019 Dec; 57(1):571-576. PubMed ID: 31456483
    [No Abstract]   [Full Text] [Related]  

  • 11. An in vitro evaluation of kratom (Mitragyna speciosa) on the catalytic activity of carboxylesterase 1 (CES1).
    Melchert PW; Zhang Q; Mukhopadhyay S; Kanumuri SRR; McCurdy CR; Markowitz JS
    Chem Biol Interact; 2023 Oct; 384():110715. PubMed ID: 37716419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations.
    Tanna RS; Tian DD; Cech NB; Oberlies NH; Rettie AE; Thummel KE; Paine MF
    J Pharmacol Exp Ther; 2021 Jan; 376(1):64-73. PubMed ID: 33093187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of inhibitory effects of caffeic acid and quercetin on human liver cytochrome p450 activities.
    Rastogi H; Jana S
    Phytother Res; 2014 Dec; 28(12):1873-8. PubMed ID: 25196644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human cytochrome P450 enzymes by licochalcone A, a naturally occurring constituent of licorice.
    He W; Wu JJ; Ning J; Hou J; Xin H; He YQ; Ge GB; Xu W
    Toxicol In Vitro; 2015 Oct; 29(7):1569-76. PubMed ID: 26100226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory mechanisms of celastrol on human liver cytochrome P450 1A2, 2C19, 2D6, 2E1 and 3A4.
    Jin C; He X; Zhang F; He L; Chen J; Wang L; An L; Fan Y
    Xenobiotica; 2015; 45(7):571-7. PubMed ID: 25811791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of cytochrome P450 enzymes CYP1A2, CYP2A6, CYP2E1 and CYP3A4 by extracts and alkaloids of Gelsemium elegans roots.
    Wang Y; Wu S; Chen Z; Zhang H; Zhao W
    J Ethnopharmacol; 2015 May; 166():66-73. PubMed ID: 25764964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tubeimoside I on the activity of cytochrome P450 enzymes in human liver microsomes.
    Wang R; Zheng K; Liu Y; Ji S; Tang Y; Wang J; Jiang R
    Xenobiotica; 2024 Feb; 54(2):57-63. PubMed ID: 38166553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro inhibition of the cytochrome P450 (CYP450) system by the antiplatelet drug ticlopidine: potent effect on CYP2C19 and CYP2D6.
    Ko JW; Desta Z; Soukhova NV; Tracy T; Flockhart DA
    Br J Clin Pharmacol; 2000 Apr; 49(4):343-51. PubMed ID: 10759690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro inhibition of Huanglian [Rhizoma coptidis (L.)] and its six active alkaloids on six cytochrome P450 isoforms in human liver microsomes.
    Han YL; Yu HL; Li D; Meng XL; Zhou ZY; Yu Q; Zhang XY; Wang FJ; Guo C
    Phytother Res; 2011 Nov; 25(11):1660-5. PubMed ID: 21425377
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Zhang J; Li C; Zhang J; Zhang F
    Xenobiotica; 2019 Oct; 49(10):1127-1132. PubMed ID: 29676195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.